Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
11.61
+0.16 (1.40%)
Nov 5, 2024, 3:49 PM EST - Market open
Viatris Employees
Viatris had 38,000 employees as of December 31, 2023. The number of employees increased by 1,000 or 2.70% compared to the previous year.
Employees
38,000
Change (1Y)
1,000
Growth (1Y)
2.70%
Revenue / Employee
$401,032
Profits / Employee
-$17,013
Market Cap
13.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 38,000 | 1,000 | 2.70% |
Dec 31, 2022 | 37,000 | 0 | - |
Dec 31, 2021 | 37,000 | -8,000 | -17.78% |
Dec 31, 2020 | 45,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Universal Health Services | 96,700 |
Solventum | 20,098 |
Revvity | 11,500 |
Exact Sciences | 6,600 |
BioMarin Pharmaceutical | 3,401 |
Incyte | 2,524 |
Genmab | 2,204 |
VTRS News
- 8 hours ago - Viatris Announces Third Quarter 2024 Dividend - PRNewsWire
- 7 days ago - Viatris Named to Forbes' World's Top Companies for Women 2024 List - PRNewsWire
- 7 days ago - Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference - PRNewsWire
- 7 days ago - Idorsia announces financial results for the first nine months of 2024 - GlobeNewsWire
- 14 days ago - Viatris Ahead Of Q3 Earnings: No Longer A 'Screaming' Bargain, But Still A Buy - Seeking Alpha
- 19 days ago - Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe - PRNewsWire
- 27 days ago - Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD) - PRNewsWire
- 4 weeks ago - Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row - PRNewsWire